A
Abecma
Abecma (idecabtagene vicleucel) is a genetically modified autologous T cell immunotherapy directed against B-cell maturation antigen (BCMA), approved for intra…
Targeted Cancer Therapies medicines and related generic ingredients.
Abecma (idecabtagene vicleucel) is a genetically modified autologous T cell immunotherapy directed against B-cell maturation antigen (BCMA), approved for intra…